U.S. label preparations
Medication directory
57 results | Page 2 of 2
- Natalizumab-sztn (Tyruko)Dilution required
- Omidubicel-onlv (Omisirge)Dilution required
- Pariglasgene brecaparvovec-opnr (Genglycos)Dilution required
- Pembrolizumab (Keytruda)Dilution required
- Pertuzumab-dpzb (Poherdy)Dilution required
- Plasminogen, human-tvmh (Ryplazim)Reconstitution only
- Rebisufligene etisparvovec-hopf (Fayuvi)No admixture required
- Remestemcel-L-rknd (Ryoncil)Dilution required
- Risankizumab-rzaa (Skyrizi)Dilution required
- Rituximab-cdxx (Zimrixby)Dilution required
- RocuroniumNeuromuscular blockadeDepends on presentation or use
- Secukinumab (Cosentyx)Dilution required
- SugammadexNeuromuscular blockadeOptional dilution
- Tocilizumab-aazg (Tyenne)Dilution required
- Tocilizumab-anoh (Avtozma)Dilution required
- Tocilizumab-bavi (Tofidence)Dilution required
- Trastuzumab-strf (Hercessi)Reconstitution and dilution
- Ustekinumab (Stelara)Dilution required / 2 reviewed statements
- Ustekinumab-aauz (Otulfi)Dilution required
- Ustekinumab-aekn (Selarsdi)Dilution required
- Ustekinumab-auub (Wezlana)Dilution required
- Ustekinumab-hmny (Starjemza)Dilution required
- Ustekinumab-kfce (Yesintek)Dilution required
- Ustekinumab-srlf (Imuldosa)Dilution required
- Ustekinumab-stba (Steqeyma)Dilution required
- Ustekinumab-ttwe (Pyzchiva)Dilution required
- VedolizumabBiologics and immunotherapyHistorical article / Reconstitution and dilution / 3 reviewed statements
Official label links, archived source snapshots, and reviewed local statements represent different levels of evidence work. Only statements with the required source mapping appear as reviewed local content.
See actual clinical evidence coverage